Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Aug. 9, 2018. Patrick Hope.

Executive Summary

Global medtech trade association DITTA says in a letter to US FDA that auditors for the flourishing Medical Device Single Audit Program aren't always applying a consistent approach when auditing. DITTA Chair Patrick Hope explains here why he sent the letter targeting MDSAP.

"We want to see more consistency in the auditing process. That's what's really behind that letter." –Patrick Hope, chair, Global Diagnostic Imaging Healthcare IT & Radiation Therapy Trade Association (DITTA)

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel